Hyperthermic isolated regional perfusion of the limb with carboplatin

This publication has 29 references indexed in Scilit:

• Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
  Journal of Clinical Oncology, 1998
• Regional Isolated Perfusion of Extremities for Melanoma: A 20-Year Experience with Drugs Other than L-Phenylalanine Mustard
  Plastic and Reconstructive Surgery, 1997
• Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and bone
  European Journal of Surgical Oncology, 1996
• Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities
  The American Journal of Surgery, 1996
• Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment
  Cancer, 1993
• Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs
  World Journal of Surgery, 1992
• Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities
  World Journal of Surgery, 1992
• A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP
  Cancer Chemotherapy and Pharmacology, 1990
• Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities
  The American Journal of Surgery, 1988
• Action of p -{Di(2-chloroethyl)}-amino-L-phenylalanine on Harding-Passey Mouse Melanoma
  Science, 1956